[Polaris Group] Correction of Endorsement Guarantee Disclosure for March 2026

1. Date of occurrence: 2026/05/27 2. Company name: LinYung Biotech Pharmaceutical Co., Ltd. 3. Relationship with the company: Subsidiary 4. Mutual shareholding ratio: Not applicable 5. Reason for occurrence: Correction of the ending balance of endorsement guarantees 6. Corrected information item/report name: Endorsement Guarantee Information Disclosure Table 7. Amount/content/page before correction: Ending balance of endorsement guarantees for March 2026: 570,000 8. Amount/content/page after correction: Ending balance of endorsement guarantees for March 2026: 555,000 9. Countermeasures: Correction implemented 10. Other matters to be stated: None